University of Missouri School of Medicine MU Health School of Medicine
News Divider
Join us on Facebook!   Follow us on Twitter!   Subscribe to us!      


Sun
Hongmin Sun, PhD, assistant professor of internal medicine at the University of Missouri, has collaborated with researchers at the University of Michigan to develop an alternative to fighting the bacteria that cause strep throat (pictured in background). Strep and similar infections affect an estimated 700 million people around the world each year.


Researchers Find New Compound to Fight Strep Throat Infection


Antibiotic alternative revealed in Proceedings of the National Academy of Sciences

Researchers have discovered a promising alternative to common antibiotics used to fight the bacteria that cause strep throat. In an article published in the Proceedings of the National Academy of Sciences, the scientists discussed how their discovery could fight the infection with a reduced risk of antibiotic resistance.

By screening tens of thousands of small molecules, the team from the University of Missouri and University of Michigan identified a class of chemical compounds that significantly reduced the severity of group A Streptococcus (GAS) bacteria infection in mice. Their work suggests that the compounds might have therapeutic value in the treatment of strep and similar infections that affect an estimated 700 million people around the world each year. The newly identified compounds could work with conventional antibiotics, such as commonly prescribed penicillin, and result in more effective treatment.

"We know that 70 percent of bacteria causing infections in the hospital are resistant to at least one of the drugs commonly used for treatment," said Hongmin Sun, PhD, the article's first author and an assistant professor of internal medicine at the University of Missouri. "Rather than killing off the bacteria, this new compound changes the behavior of the bacteria and makes it less harmful."

Current antibiotics interfere with critical biological processes in the pathogen to kill it or stop its growth. But at the same time, stronger strains of harmful bacteria can sometimes resist the treatment and flourish.

"The widespread occurrence of antibiotic resistance among human pathogens is a major public health problem," said David Ginsburg, MD, a professor of internal medicine, human genetics, and pediatrics at the University of Michigan and a Howard Hughes Medical Institute investigator.

Ginsburg and Sun collaborated on a research team that included Scott Larsen, PhD, research professor of medicinal chemistry and co-director of the Vahlteich Medicinal Chemistry Core at the University of Michigan's College of Pharmacy. Work on this project is continuing in Sun's lab at the University of Missouri and at the University of Michigan, including the preparation of new compounds with improved potency and the filing of patents, Larsen said.





Missouri Health News Network

Divider

News and Events

Frederick Fraunfelder, MD Tulane Cardiovascular Researcher Named School of Medicine Dean
Patrice Delafontaine, MD, is accomplished physician-scientist, educator, administrator

Frederick Fraunfelder, MD Fraunfelder Joins MU School of Medicine as Chair of Ophthalmology
Fraunfelder specializes in corneal disease, cancers of the eye and laser surgery

Karl D. Nolph, MD In Memoriam: Karl D. Nolph, MD
Nephrology leader was pioneer in the field of dialysis

Class of 2014 Race Could Be a Factor in Head and Neck Cancer Survival Rates
Prognosis has not improved for African-Americans

Class of 2014 Ninety-Seven New Physicians to Graduate from MU Medical School
Many of the graduates stay in state for residency and train in primary care

Brown Brown Recognized by Association of American Medical Colleges
Award recognizes exemplary service in student affairs

Fete $500,000 Pledged for Pediatric Research at MU School of Medicine
New donation increases funding from Leda J. Sears Trust to $1.2 million

Hoffman Hoffman Accepted into Leadership Development Program
Education leader among 54 women named to Drexel University program

Baumhardt Trust Provides Scholarship Support for MU, UMKC Students
Gift awards student with best paper on schizophrenia

St. Baldricks 2014 MU Medical Students Shave Their Heads for Cancer Research
Event supports pediatric cancer studies funded by St. Baldrick's Foundation

Fleming MU Department of Medicine Chair to Lead Medical Speciality Group
Fleming elected president of American College of Physicians

Howenstine MU Medical Students Shave Heads to Raise Funds for Cancer Research
Kickoff event begins efforts which raises thousands for pediatric cancer




Media Relations
University of Missouri Health System
One Hospital Drive, DC028.00
Columbia, MO 65212
24/7 on-call pager: (573) 876-0708

Mary Jenkins
jenkinsmg@health.missouri.edu
(573) 882-7299

Jeff Hoelscher
hoelscherj@health.missouri.edu
(573) 884-1608

Derek Thompson
thompsonder@health.missouri.edu
(573) 882-3323


Web Communications
University of Missouri Health System
One Hospital Drive, MA204G, DC018.00
Columbia, MO 65212
(573) 884-0298

Rich Gleba
glebar@health.missouri.edu
(573) 884-0298

Laura Gerding, APR
gerdingla@health.missouri.edu
(573) 882-9193

Velvet Hasner
hasnerv@health.missouri.edu
(573) 884-1115

Mike Muin
muinm@health.missouri.edu
(573) 884-7541



Printer Friendly
Follow us on Twitter!   Facebook   YouTube Videos  
Website created and maintained by the Office of Communications.
Contact the MU School of Medicine.
Revised: April 27, 2013 - Copyright © 2013 - The Curators of the University of Missouri System.
All rights reserved. DMCA and other copyright information. An equal opportunity/affirmative action institution.